Open AccessTherapeutic Effects of HESA-A in Patients With End-Stage Metastatic Cancers
Author(s) -
Amrollah Ahmadi,
Mohammad Ali Mohagheghi,
Mehrdad Karimi,
Seyed Ali Golestanha,
Mohsen Naseri,
Soghrat Faghihzadeh,
Gholamreza Habibi
Publication year - 2010
Publication title -
integrative cancer therapies
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.73
H-Index - 60
eISSN - 1552-695X
pISSN - 1534-7354
DOI - 10.1177/1534735409357934
Subject(s) - medicine , adverse effect , cancer , stage (stratigraphy) , performance status , clinical trial , metastasis , oncology , biology , paleontology
After cardiovascular disease, cancer is the most common cause of death. HESA-A is a natural product of herbal and marine origin. The aim of this study was to investigate the beneficial effects of HESA-A in patients with end-stage metastatic cancers.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom